← Evidence map

ArticleJournal of oncology2022

Recurrent Ameloblastoma: Clinical Manifestation and Disease-Free Survival Rate.

Andrii Hresko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35983087